• First-ever leader of Sandoz’s Global Public Affairs and External Engagement team, responsible for developing and implementing a comprehensive strategic approach to global public affairs advocacy, the development Sandoz's position on important global public policy issues, engagement with patient organizations, EU public affairs, and interactions with WHO, WTO, other UN organizations, global trade associations, and stakeholders.• Built a highly cooperative and effective team, the first since Sandoz’s spin-off from Novartis, that works with colleagues throughout the company to advance Sandoz's core corporate objectives through public policy advocacy and engagement.• Spearhead Sandoz’s global public policy efforts, ensuring Sandoz's leadership understands the landscape of proposed and forthcoming government policy proposals. • Drive initiatives that enhance Sandoz’s global presence and influence in public affairs and external engagement.• Work closely with the U.S. public affairs and patient engagement team to ensure cohesive and aligned strategies.

• Led the development of AAM’s new Strategic Plan.• Engaged and counseled global CEOs and AAM Board members on key industry priorities.• Served as Chair (and AAM board representative) of the International Generic and Biosimilar Industry Association (IGBA).• Led and coordinated AAM’s CEO Roundtable, Supply Chain and Trade Working Groups, and, in partner with international colleagues, IGBA’s CEO Advisory Committee.• Served as AAM’s media and public spokesperson on supply chain, trade, and international issues.• Actively partnered with and lobbied the U.S. Government, Congress, and other stakeholders.• Crafted integrated public policy advocacy strategies to advance AAM’s supply chain, trade, and international affairs agenda.• Active member of AAM’s Leadership Team and Membership Task Force.• Successfully led AAM’s USMCA integrated advocacy campaign to winning outcome.

• Led multiple client account teams that implemented complex integrated communication strategies to advance media, public affairs, and advocacy objectives for pharmaceutical, medical device, and other healthcare clients.• Drove new business growth, targeting a broad range of clients seeking healthcare policy, marketing, and communications support.• Developed, mentored, and led a revitalized U.S. healthcare public affairs and policy team to address key communication challenges for companies across the healthcare sector.

• Led PhRMA’s Europe, Middle East, Africa, and the Americas (EMAA) advocacy programs, including an annual budget of up to $3.8 million that funds projects throughout the EMAA region. • Forged consensus among PhRMA member companies on public policy positions. • Developed, led, and implemented public policy advocacy and communications initiatives. • Advanced common positions with a broad range of healthcare stakeholders and allied organizations, including senior U.S. and foreign government officials, patient organizations, and other trade associations.• Developed and promoted efforts to engage cooperatively with governments on key healthcare reforms issues.• Counseled and managed staff in Washington and Dubai.• Organized meetings and conferences focused on key advocacy issues impacting PhRMA member companies in the EMAA region. • Built strong working relationship with partner associations throughout the EMAA region. • Engaged in public speaking and media activities. Honors: Received the President’s Management Leadership Award (January 2014).

• Managed a team of four Desk Officers working to ensure fair market access for U.S. companies active in 16 markets in Central and Southeastern Europe (CSE).• Provided policy guidance to senior Commerce Department officials, including the Secretary, Deputy Secretary, and others, in meetings with their counterparts from CSE.• Developed strategies to support U.S. companies as they seek to overcome trade barriers throughout CSE, with particular emphasis on issues impacting IPR enforcement.

• Advised U.S. companies on regulations and barriers affecting U.S. exports and investors.• Drafted speeches and background papers for Secretary of Commerce and other senior government officials.• Represented the U.S. Government in meetings with senior foreign government, including meetings with Ministers of foreign governments.• Developed U.S. Government commercial policy affecting the Balkans.Honors: Received the Under Secretary's Award in spring 2000 and fall 2003. Received Special Recognition Awards in December 1999, September 2000, September 2001, and June 2002. Selected to participate in Executive Leadership Development Program (2005-2006).

• Managed a team of eight Research Assistants. • Directed a research project evaluating best practices for fiscal decentralization in Central and Eastern Europe.• Edited The Transfer of Power: Decentralization in Central and Eastern Europe, a collection of seven papers focusing on fiscal and political decentralization in Central and Eastern Europe. George Soros’ Open Society Institute published this book in 1999.

• Managed the U.S. Internship Program that provided training opportunities for Central and Eastern Europe policy experts in policy institutes in the United States.• Managed the Regional Exchange Program that promoted cooperation between policy institutes in eleven Central and Eastern Europe countries.• Regional coordinator for an eleven-country program to support public policy institutes in Central and Eastern Europe.